Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: HSBC Cuts Shell Buts Raises Next

Fri, 01st May 2020 09:32

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday afternoon:

----------

FTSE 100

----------

HSBC CUTS SHELL TO 'HOLD' (BUY)

----------

GOLDMAN SACHS CUTS SHELL B PRICE TARGET TO 1850 (2000) PENCE - 'BUY'

----------

BERENBERG CUTS SHELL B TO 'HOLD' (BUY) - PRICE TARGET 1440 (1450) PENCE

----------

HSBC RAISES NEXT TO 'BUY' ('HOLD') - TARGET 5570 (7050) PENCE

----------

UBS RAISES WHITBREAD TO 'BUY' ('NEUTRAL') - TARGET 3610 (4875) PENCE

----------

LIBERUM CUTS HARGREAVES LANSDOWN TO 'HOLD' ('BUY') - TARGET 1540 (2075) PENCE

----------

BARCLAYS RAISES ST JAMES'S PLACE TARGET TO 1118 (1098) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES ASTRAZENECA PRICE TARGET TO 9200 (9000) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES RECKITT BENCKISER PRICE TARGET TO 5900 (5860) PENCE - 'HOLD'

----------

BARCLAYS RAISES RECKITT BENCKISER PRICE TARGET TO 7900 (6900) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES RECKITT BENCKISER PRICE TARGET TO 7450 (7350) PENCE - 'BUY'

----------

HSBC RAISES RECKITT BENCKISER PRICE TARGET TO 7300 (7000) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES FERGUSON PRICE TARGET TO 6600 (5900) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS BAE SYSTEMS PRICE TARGET TO 695 (730) PENCE - 'BUY'

----------

CREDIT SUISSE CUTS SHELL PRICE TARGET TO 1700 (1900) PENCE - 'OUTPERFORM'

----------

UBS CUTS INTERCONTINENTAL HOTELS PRICE TARGET TO 3900 (4150) PENCE - 'NEUTRAL'

----------

BERENBERG RAISES BARCLAYS PRICE TARGET TO 160 (150) PENCE - 'BUY'

----------

JPMORGAN RAISES ASTRAZENECA PRICE TARGET TO 9500 (8500) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS MELROSE INDUSTRIES PRICE TARGET TO 165 (180) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES SHELL PRICE TARGET TO 1150 (1140) PENCE - 'HOLD'

----------

RBC RAISES SHELL B PRICE TARGET TO 1800 (1700) PENCE - 'OUTPERFORM'

----------

GOLDMAN SACHS RAISES RECKITT BENCKISER PRICE TARGET TO 6300 (5950) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS CUTS INTERNATIONAL CONSOLIDATED AIRLINES TO 'NEUTRAL' (BUY) - PRICE TARGET 250 (500) PENCE

----------

CREDIT SUISSE RAISES RECKITT BENCKISER PRICE TARGET TO 6100 (5900) PENCE - 'NEUTRAL'

----------

DZ BANK RAISES FAIR VALUE FOR RECKITT BENCKISER TO 7100 (6500) PENCE - 'BUY'

----------

DZ BANK RAISES FAIR VALUE FOR GLAXOSMITHKLINE TO 1950 (1900) PENCE - 'BUY'

----------

RBC RAISES RECKITT BENCKISER PRICE TARGET TO 4900 (4600) PENCE - 'UNDERPERFORM'

----------

DZ BANK RAISES FAIR VALUE FOR ASTRAZENECA TO 7300 (6500) PENCE - 'SELL'

----------

RBC CUTS RSA INSURANCE PRICE TARGET TO 550 (600) PENCE - 'OUTPERFORM'

----------

CREDIT SUISSE RAISES ASHTEAD GROUP TARGET TO 2500 (2050) PENCE - 'OUTPERFORM'

----------

FTSE 250

----------

BARCLAYS CUTS JOHN LAING PRICE TARGET TO 425 (440) PENCE - 'EQUAL WEIGHT'

----------

LIBERUM CUTS RATHBONE BROTHERS PRICE TARGET TO 1520 (2100) PENCE - 'HOLD'

----------

LIBERUM RAISES INTEGRAFIN PRICE TARGET TO 455 (435) PENCE - 'HOLD'

----------

LIBERUM CUTS QUILTER PRICE TARGET TO 145 (185) PENCE - 'BUY'

----------

LIBERUM CUTS BREWIN DOLPHIN HOLDINGS PRICE TARGET TO 330 (384) PENCE - 'BUY'

----------

CREDIT SUISSE CUTS IMI PRICE TARGET TO 800 (950) PENCE - 'UNDERPERFORM'

----------

JPMORGAN RAISES CONVATEC PRICE TARGET TO 167 (160) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS KAZ MINERALS PRICE TARGET TO 380 (400) PENCE - 'NEUTRAL'

----------

BERENBERG RAISES SYNTHOMER PRICE TARGET TO 330 (260) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES CONVATEC PRICE TARGET TO 180 (175) PENCE - 'UNDERPERFORM'

----------

OTHER MAIN MARKET AND AIM

----------

BERENBERG INITIATES AB DYNAMICS WITH 'BUY' - TARGET 2050 PENCE

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.